Health Care - As enacted, authorizes a physician to perform stem cell therapy or regenerative medicine therapy that is not approved by the United States food and drug administration if such therapy is used for a treatment or procedure that is within the scope of practice of the physician; makes related changes. - Amends TCA Title 63 and Title 68.

Voted 5/26/2026View source

Summary

No summary has been published for this bill yet.

Bill text

The full text of this bill isn't on Heard yet. The official documents are linked below.

Roll-call record

How representatives voted

9 yea·0 nay

Docket history

5/26/2026Comp. became Pub. Ch. 1016
4/17/2026Sponsor(s) Added.
4/16/2026Companion House Bill substituted
4/15/2026Senate Reset on calendar for 4/16/2026
4/15/2026Placed on Senate Regular Calendar for 4/16/2026
4/15/2026Sponsor(s) Added.
4/13/2026Placed on Senate Regular Calendar for 4/15/2026
4/1/2026Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0
3/25/2026Placed on Senate Health and Welfare Committee calendar for 4/1/2026
3/18/2026Reset on Final calendar of Senate Health and Welfare Committee